PRNAF
ALTERITY THERAPEUTICS LTD by Alterity Therapeutics Limited (PRNAF)
$01
About ALTERITY THERAPEUTICS LTD by Alterity Therapeutics Limited (PRNAF)
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
105.5M
Dividend yield
0.00%
Volume
--
Avg. volume
947
P/E ratio
-8.08
ALTERITY THERAPEUTICS LTD by Alterity Therapeutics Limited News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
105.5M
Dividend yield
0.00%
Volume
--
Avg. volume
947
P/E ratio
-8.08